BIRDSEYE THERAPEUTICS
LIVE

Serial Number

99909103

Owner

Birdseye Therapeutics, Inc.

Attorney

Joi A. White

Filing Date

Jun 26, 2026

Add to watchlist:

No watchlists yet
View on USPTO

BIRDSEYE THERAPEUTICS Trademark

Serial Number: 99909103

BIRDSEYE THERAPEUTICS is a trademark filed by Birdseye Therapeutics, Inc. on June 26, 2026. The trademark is classified under Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Birdseye Therapeutics, Inc. (2 trademarks)

1616 Eastlake Ave E, Suite 550
Seattle, WA 98102

Entity Type: 03

Trademark Details

Filing Date

June 26, 2026

Registration Date

Not Registered

Goods & Services

Scientific research and development; medical research; biotechnology research; biomedical research services; research and development in the pharmaceutical and biotechnology fields; pharmaceutical research and development; pharmaceutical research services; product research and development; research and development services in the field of antibodies; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; laboratory research services relating to pharmaceuticals; drug discovery services; pharmaceutical drug development services; provision, identification and development of therapeutic proteins, antibodies, reagents, multi-specific biologics and multi-specific antibodies; providing information about medical and scientific research in the fields of pharmaceuticals; providing information about medical research; provision of information about clinical trials; providing medical and scientific research information in the field of clinical trials; provision of information in the fields of therapeutics, biotherapeutics, medicines, pharmaceuticals, and drugs; provision of information about proteins, therapeutic proteins, engineered proteins, antibodies, therapeutic antibodies, engineered antibodies, antibody therapies, and antibodies for medical use and purposes, multi-specific biologics, and multi-specific antibodies; providing a website featuring scientific information about therapeutics, biotherapeutics, pharmaceuticals, medicines, and drugs; providing a website featuring scientific information about proteins, therapeutic proteins, engineered proteins, antibodies, therapeutic antibodies, engineered antibodies, antibody therapies, and antibodies for medical use and purposes, multi-specific biologics, and multi-specific antibodies

Filing History

APPLICATION FILING RECEIPT MAILED
Jun 26, 2026 MAFR
NEW APPLICATION ENTERED
Jun 26, 2026 NWAP